KKUR Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
KKUR FAQ
What was ChromoCure Inc’s price range in the past 12 months?
Currently, no data Available
What is ChromoCure Inc’s market cap?
ChromoCure Inc’s market cap is $8.20K.
When is ChromoCure Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ChromoCure Inc’s earnings last quarter?
Currently, no data Available
Is ChromoCure Inc overvalued?
According to Wall Street analysts ChromoCure Inc’s price is currently Overvalued.
Does ChromoCure Inc pay dividends?
ChromoCure Inc does not currently pay dividends.
What is ChromoCure Inc’s EPS estimate?
ChromoCure Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ChromoCure Inc have?
ChromoCure Inc has 8,200,000,000 shares outstanding.
What happened to ChromoCure Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ChromoCure Inc?
Currently, no hedge funds are holding shares in KKUR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ChromoCure Inc
ChromoCure, Inc. specializes in designing and delivering exclusive systems for cancer identification. Their primary offering, the Chromosomal Scanner Series 200, is a detection system capable of identifying a distinct genomic characteristic that is universally present in all cancers yet entirely absent in healthy cells. Furthermore, the company dedicates its scientific and technological expertise to investigating non-toxic and non-invasive strategies for both cancer treatment and cure research. Established in 2001 and based in Reno, Nevada, the organization rebranded as ChromoCure, Inc. in June 2009, having previously been known as Cyberhand Technologies International, Inc.
Scinai Immunotherapeutics
―
NewcelX
―
Dermata Therapeutics
―
Bluejay Diagnostics
―
Virax Biolabs Group Ltd. Class A
―